Cerevel Therapeutics Hldg Inc (CERE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 320,436 | 416,465 | 155,721 | 175,763 | 153,816 |
| Marketable Securities | 525,858 | 574,500 | 521,161 | 560,663 | 673,171 |
| TOTAL | $859,577 | $1,006,938 | $687,786 | $751,673 | $840,782 |
| Non-Current Assets | |||||
| PPE Net | 24,929 | 25,647 | 26,613 | 27,246 | 27,006 |
| Investments And Advances | 218,591 | 185,199 | 81,340 | 88,637 | 36,048 |
| Other Non-Current Assets | 24,246 | 25,514 | 26,223 | 26,797 | 26,509 |
| TOTAL | $267,766 | $236,360 | $134,176 | $142,680 | $89,563 |
| Total Assets | $1,127,343 | $1,243,298 | $821,962 | $894,353 | $930,345 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,839 | 11,863 | 11,541 | 9,389 | 7,315 |
| Accrued Expenses | 69,750 | 76,912 | 64,021 | 53,021 | 52,614 |
| TOTAL | $84,104 | $92,179 | $78,838 | $65,560 | $62,957 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 478,784 | 477,374 | 470,162 | 478,293 | 435,679 |
| TOTAL | $478,784 | $477,374 | $470,162 | $478,293 | $435,679 |
| Total Liabilities | $562,888 | $569,553 | $549,000 | $543,853 | $498,636 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 182,195 | 181,577 | 180,278 | 157,488 | 156,833 |
| Common Shares | 18 | 18 | 16 | 16 | 16 |
| Retained earnings | -1,532,509 | -1,400,597 | -1,267,937 | -1,171,576 | -1,072,041 |
| Other shareholders' equity | -1,089 | 1,771 | 1,682 | 1,142 | 3,688 |
| TOTAL | $564,455 | $673,745 | $272,962 | $350,500 | $431,709 |
| Total Liabilities And Equity | $1,127,343 | $1,243,298 | $821,962 | $894,353 | $930,345 |